ID: ALA5179120

Max Phase: Preclinical

Molecular Formula: C14H23NO2S2

Molecular Weight: 301.48

Associated Items:

Representations

Canonical SMILES:  O=S(=O)(NC12CC3CC(CC(C3)C1)C2)C1CCCS1

Standard InChI:  InChI=1S/C14H23NO2S2/c16-19(17,13-2-1-3-18-13)15-14-7-10-4-11(8-14)6-12(5-10)9-14/h10-13,15H,1-9H2

Standard InChI Key:  RIMMCGONNWJCIV-UHFFFAOYSA-N

Associated Targets(Human)

Gamma-secretase 4915 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 301.48Molecular Weight (Monoisotopic): 301.1170AlogP: 2.73#Rotatable Bonds: 3
Polar Surface Area: 46.17Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.63CX Basic pKa: CX LogP: 2.15CX LogD: 2.15
Aromatic Rings: 0Heavy Atoms: 19QED Weighted: 0.87Np Likeness Score: -0.44

References

1. Kumar N, Kumar V, Anand P, Kumar V, Ranjan Dwivedi A, Kumar V..  (2022)  Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease.,  61  [PMID:35398739] [10.1016/j.bmc.2022.116742]

Source